Metabolic effects of carbon monoxide in relation to atherogenesis.
The acute and chronic effects of carbon monoxide (CO) are reviewed. Direct effects of CO-induced hypoxia on arterial metabolism may facilitate deposition of cholesterol in the intimal surface and exacerbate existing atherosclerosis. Other studies indicate that CO may alter hepatic metabolism so as to inhibit both the secretion of very low density lipoproteins and the clearance of chylomicron remnants. The former change would diminish and the latter enhance atherogenesis. These findings are considered and avenues of future investigation suggested.
D000818:Animals; D001158:Arteries / Q000378:metabolism; D001161:Arteriosclerosis / Q000209:etiology*; D002248:Carbon Monoxide / Q000009:adverse effects* / Q000494:pharmacology; D002263:Carboxyhemoglobin / Q000494:pharmacology; D002784:Cholesterol / Q000378:metabolism; D003327:Coronary Disease / Q000209:etiology; D005227:Fatty Acids / Q000378:metabolism; D000882:Haplorhini; D006801:Humans; D008079:Lipoproteins, VLDL / Q000378:metabolism; D008297:Male; D010084:Oxidation-Reduction / Q000187:drug effects; D010101:Oxygen Consumption / Q000187:drug effects; D011817:Rabbits; D051381:Rats; D012907:Smoking / Q000150:complications
D005227:Fatty Acids; D008079:Lipoproteins, VLDL; D002248:Carbon Monoxide; D002263:Carboxyhemoglobin; D002784:Cholesterol